This inventor holds 1 USPTO granted patent. Top assignee: Prophylix Pharma as. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Anne Husse-Bekk: Innovator in Neonatal Health
Introduction
Anne Husse-Bekk is a notable inventor based in Tromso, Norway. She has made significant contributions to the field of neonatal health, particularly in the prevention of neonatal alloimmune thrombocytopenia (NAIT). Her innovative approach aims to improve outcomes for mothers and their newborns.
Latest Patents
Anne holds a patent for a preparation useful for, and a method for the treatment of neonatal alloimmune thrombocytopenia (NAIT). This preparation is designed for the prophylactic treatment of women post-childbirth to prevent immunization and antibody production that could lead to NAIT and fetal/neonatal bleeding in subsequent pregnancies. The method involves administering a preparation containing antibodies to HPA1a within 72 hours after delivery in the first non-compatible pregnancy.
Career Highlights
Anne is currently associated with Prophylix Pharma, where she continues to develop her innovative ideas. Her work is crucial in addressing the challenges faced by mothers and infants in the context of NAIT.
Collaborations
Anne collaborates with esteemed colleagues such as Bjorn Ragnar Skogen and Mette Kjaer Killie. Their combined expertise enhances the research and development efforts at Prophylix Pharma.
Conclusion
Anne Husse-Bekk's contributions to neonatal health through her innovative patent demonstrate her commitment to improving maternal and infant health outcomes. Her work is paving the way for advancements in the treatment of neonatal alloimmune thrombocytopenia.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile